Publications

International journal of radiation oncology, biology, physics

In Regard to Redmond et al.

01-09-2017

PloS one

Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.

08-03-2017

Current opinion in supportive and palliative care

Cancer-related cognitive impairment and patients' ability to work: a current perspective.

01-03-2017

The Clinical neuropsychologist

Online cognition: factors facilitating reliable online neuropsychological test results.

01-01-2017

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design.

01-01-2017

Psychology & health

Increased cognitive problem reporting after information about chemotherapy-induced cognitive decline: The moderating role of stigma consciousness.

01-01-2017

Journal of pain and symptom management

Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study.

01-10-2016

Acta oncologica (Stockholm, Sweden)

Neurocognitive function of lymphoma patients after treatment with chemotherapy.

23-06-2016

Behavioural brain research

Neurobiological changes by cytotoxic agents in mice.

15-02-2016

Psycho-oncology

Reliable change in neuropsychological assessment of breast cancer survivors.

01-01-2016

Journal of pain and symptom management

Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.

01-12-2015

Psycho-oncology

Late effects of adjuvant chemotherapy for breast cancer on fine motor function.

01-12-2015

Human brain mapping

Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy.

01-11-2015

Nature reviews. Clinical oncology

Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

01-10-2015

Brain imaging and behavior

Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type.

01-06-2015

NeuroImage. Clinical

Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue.

07-04-2015

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy.

20-02-2015

Journal of the International Neuropsychological Society : JINS

Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors.

01-01-2015

Psychopharmacology

Cognitive impact of cytotoxic agents in mice.

01-01-2015

Menopause (New York, N.Y.)

Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.

01-01-2015

EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]

Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.

01-06-2014

Journal of the International Neuropsychological Society : JINS

Systemically treated breast cancer patients and controls: an evaluation of the presence of noncredible performance.

01-04-2014

Human brain mapping

Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy.

01-03-2014

Brain imaging and behavior

Functional MRI studies in non-CNS cancers.

01-12-2013

Brain imaging and behavior

Chemotherapy-related cognitive dysfunction: current animal studies and future directions.

01-12-2013

Critical reviews in oncology/hematology

Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.

01-10-2013

EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]

Chemotherapy-related changes in cognitive functioning.

01-09-2013

Human brain mapping

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.

01-12-2012

Psycho-oncology

Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.

01-10-2012

Psycho-oncology

Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.

01-05-2012

Human brain mapping

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

01-08-2011

Critical reviews in oncology/hematology

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.

01-11-2010

Psycho-oncology

The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy.

01-04-2010

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.

10-03-2010

Psycho-oncology

The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.

01-06-2009

Acta oncologica (Stockholm, Sweden)

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.

09-09-2008

Nederlands tijdschrift voor geneeskunde

[The effect of hormone therapy on cognitive function in patients with breast cancer].

01-03-2008

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy.

01-03-2008

Clinical breast cancer

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer.

01-02-2008

Acta oncologica (Stockholm, Sweden)

Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.

16-10-2007

The Lancet. Oncology

Cognitive dysfunction in people with cancer.

01-10-2007

Minerva ginecologica

Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.

01-08-2007

Journal of the National Cancer Institute

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.

06-12-2006

Clinical breast cancer

Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.

01-04-2006

Breast cancer research and treatment

Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy.

01-11-2005

Clinical breast cancer

Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.

01-12-2002

Annals of oncology : official journal of the European Society for Medical Oncology

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.

01-09-2002

Journal of neuro-oncology

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.

01-01-2001

Cancer

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

01-02-1999

Journal of the National Cancer Institute

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

04-02-1998

In Regard to Redmond et al.

Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.

Cancer-related cognitive impairment and patients' ability to work: a current perspective.

Online cognition: factors facilitating reliable online neuropsychological test results.

Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design.

Increased cognitive problem reporting after information about chemotherapy-induced cognitive decline: The moderating role of stigma consciousness.

Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study.

Neurocognitive function of lymphoma patients after treatment with chemotherapy.

Neurobiological changes by cytotoxic agents in mice.

Reliable change in neuropsychological assessment of breast cancer survivors.

Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012.

Late effects of adjuvant chemotherapy for breast cancer on fine motor function.

Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy.

Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type.

Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue.

Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy.

Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors.

Cognitive impact of cytotoxic agents in mice.

Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.

Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.

Systemically treated breast cancer patients and controls: an evaluation of the presence of noncredible performance.

Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy.

Functional MRI studies in non-CNS cancers.

Chemotherapy-related cognitive dysfunction: current animal studies and future directions.

Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.

Chemotherapy-related changes in cognitive functioning.

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.

Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.

Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.

The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy.

Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.

The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.

[The effect of hormone therapy on cognitive function in patients with breast cancer].

ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy.

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer.

Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.

Cognitive dysfunction in people with cancer.

Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.

Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.

Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy.

Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

This site uses cookies